# Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer

> **NCT00005981** · PHASE2 · COMPLETED · sponsor: **Case Comprehensive Cancer Center** · enrollment: 13 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** O6-benzylguanine
- **DRUG:** carmustine

## Key facts

- **NCT ID:** NCT00005981
- **Lead sponsor:** Case Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-06
- **Primary completion:** 2003-11
- **Final completion:** 2003-11
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2010-06-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005981

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005981, "Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00005981. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*